O

Ocugen
D

OCGN

0.73640
USD
-0.03
(-3.59%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-4
Market Cap
214,528,254
OverviewSignalsIdeasNews
Related Instruments
    A
    ADVM
    -0.00500
    (-0.11%)
    4.73000 USD
    A
    ALT
    -0.50500
    (-6.10%)
    7.77000 USD
    BNTX
    BNTX
    0.420
    (0.37%)
    113.470 USD
    C
    CODX
    -0.00100
    (-0.14%)
    0.72900 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    I
    INO
    -0.04500
    (-2.46%)
    1.78500 USD
    MRNA
    MRNA
    0.270
    (0.69%)
    39.630 USD
    N
    NVAX
    -0.08000
    (-0.92%)
    8.64000 USD
    V
    VAXX
    0.000000
    (0.00%)
    0.000000 USD
    V
    VXRT
    -0.01110
    (-1.81%)
    0.60150 USD
    More
News

Title: Ocugen

Sector: Healthcare
Industry: Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").